- Home
- SCLXW vs LTRYW Comparison
SCLXW vs LTRYW Comparison
Compare SCLXW & LTRYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLXW
- LTRYW
- Stock Information
- Founded
- SCLXW N/A
- LTRYW N/A
- Country
- SCLXW United States
- LTRYW United States
- Employees
- SCLXW 115
- LTRYW 12
- Industry
- SCLXW Biotechnology: Pharmaceutical Preparations
- LTRYW Computer Software: Prepackaged Software
- Sector
- SCLXW Health Care
- LTRYW Technology
- Exchange
- SCLXW Nasdaq
- LTRYW Nasdaq
- Market Cap
- SCLXW N/A
- LTRYW N/A
- IPO Year
- SCLXW N/A
- LTRYW 2023
- Fundamental
- Price
- SCLXW $0.11
- LTRYW $0.02
- Analyst Decision
- SCLXW
- LTRYW
- Analyst Count
- SCLXW 0
- LTRYW 0
- Target Price
- SCLXW N/A
- LTRYW N/A
- AVG Volume (30 Days)
- SCLXW 4.0K
- LTRYW N/A
- Earning Date
- SCLXW 03-07-2025
- LTRYW N/A
- Dividend Yield
- SCLXW N/A
- LTRYW N/A
- EPS Growth
- SCLXW N/A
- LTRYW N/A
- EPS
- SCLXW N/A
- LTRYW N/A
- Revenue
- SCLXW $55,152,000.00
- LTRYW N/A
- Revenue This Year
- SCLXW N/A
- LTRYW N/A
- Revenue Next Year
- SCLXW N/A
- LTRYW N/A
- P/E Ratio
- SCLXW N/A
- LTRYW N/A
- Revenue Growth
- SCLXW 22.02
- LTRYW N/A
- 52 Week Low
- SCLXW $0.18
- LTRYW N/A
- 52 Week High
- SCLXW $0.18
- LTRYW N/A
- Technical
- Relative Strength Index (RSI)
- SCLXW N/A
- LTRYW N/A
- Support Level
- SCLXW N/A
- LTRYW N/A
- Resistance Level
- SCLXW N/A
- LTRYW N/A
- Average True Range (ATR)
- SCLXW 0.00
- LTRYW 0.00
- MACD
- SCLXW 0.00
- LTRYW 0.00
- Stochastic Oscillator
- SCLXW 0.00
- LTRYW 0.00
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About LTRYW Lottery.com Inc.
Lottery.com Inc is a provider of domestic and international lottery products and services. As an independent third-party lottery game service, the Company offers a platform that it developed and operates to enable the remote purchase of legally sanctioned lottery games in the U.S. and abroad. The Company's revenue-generating activities are focused on (i) offering the Platform via the Lottery.com app and its websites to users located in the U.S. and international jurisdictions where the sale of lottery games is legal and its services are enabled for the remote purchase of legally sanctioned lottery games; (ii) offering an internally developed, created and operated business-to-business application programming interface of the Platform to enable commercial partners in permitted U.S.